A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran
- PMID: 22451729
- PMCID: PMC3309046
- DOI: 10.3347/kjp.2012.50.1.15
A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran
Abstract
In Iran, Plasmodium vivax is responsible for more than 80% of the infected cases of malaria per year. Control interventions for vivax malaria in humans rely mainly on developed diagnostic methods. Recombinant P. vivax apical membrane antigen-1 (rPvAMA-1) has been reported to achieve designing rapid, sensitive, and specific molecular diagnosis. This study aimed to perform isolation and expression of a rPvAMA-1, derived from Iranian patients residing in an endemic area. Then, the diagnostic efficiency of the characterized Iranian PvAMA-1 was assessed using an indirect ELISA method. For this purpose, a partial region of AMA-1 gene was amplified, cloned, and expressed in pET32a plasmid. The recombinant His-tagged protein was purified and used to coat the ELISA plate. Antibody detection was assessed by indirect ELISA using rPvAMA-1. The validity of the ELISA method for detection of anti-P. vivax antibodies in the field was compared to light microscopy on 84 confirmed P. vivax patients and compared to 84 non-P. vivax infected individuals. The ELISA cut-off value was calculated as the mean+2SD of OD values of the people living in malaria endemic areas from a south part of Iran. We found a cut-off point of OD=0.311 that showed the best correlation between the sera confirmed with P. vivax infection and healthy control sera. A sensitivity of 81.0% and specificity of 84.5% were found at this cut off titer. A good degree of statistical agreement was found between ELISA using rPvAMA-1 and light microscopy (0.827) by Kappa analysis.
Keywords: AMA-1; ELISA; Iran; Plasmodium vivax; microscopy; recombinant antigen.
Figures


Similar articles
-
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients.Eur J Med Res. 2021 Nov 25;26(1):134. doi: 10.1186/s40001-021-00607-6. Eur J Med Res. 2021. PMID: 34823591 Free PMC article.
-
Evaluation of Naturally Acquired Antibody Responses to Two Variant Forms of Plasmodium vivax Apical Membrane Antigen-1 in Individuals Living in Areas of Low and Unstable Malaria Transmission of Iran.Arch Iran Med. 2015 Dec;18(12):834-43. Arch Iran Med. 2015. PMID: 26621016
-
Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.J Microbiol Methods. 2016 Apr;123:44-50. doi: 10.1016/j.mimet.2016.02.003. Epub 2016 Feb 3. J Microbiol Methods. 2016. PMID: 26851675
-
Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.Malar J. 2019 Dec 16;18(1):425. doi: 10.1186/s12936-019-3066-6. Malar J. 2019. PMID: 31842894 Free PMC article.
-
Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes.Cell Microbiol. 2020 Jan;22(1):e13110. doi: 10.1111/cmi.13110. Epub 2019 Sep 8. Cell Microbiol. 2020. PMID: 31469946 Free PMC article. Review.
Cited by
-
Genetic Diversity in C-terminal of SERA5 Gene in the Blood Stage of Human Isolates of Plasmodium vivax in Sistan and Baluchistan, Iran.Iran J Parasitol. 2018 Jul-Sep;13(3):440-447. Iran J Parasitol. 2018. PMID: 30483336 Free PMC article.
-
Allelic Variations of Plasmodium vivax Apical Membrane Antigen-1 (Pv AMA-1) in Malarious Areas of Southeastern Iran Using PCR-RFLP Technique.Iran J Parasitol. 2018 Jul-Sep;13(3):473-479. Iran J Parasitol. 2018. PMID: 30483340 Free PMC article.
-
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients.Eur J Med Res. 2021 Nov 25;26(1):134. doi: 10.1186/s40001-021-00607-6. Eur J Med Res. 2021. PMID: 34823591 Free PMC article.
-
Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-142 (MSP-142).Malar J. 2013 Dec 19;12:454. doi: 10.1186/1475-2875-12-454. Malar J. 2013. PMID: 24354660 Free PMC article.
-
Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region.PLoS One. 2018 Nov 12;13(11):e0207244. doi: 10.1371/journal.pone.0207244. eCollection 2018. PLoS One. 2018. PMID: 30419071 Free PMC article.
References
-
- Greenwood B, Mutabingwa T. Malaria in 2002. Nature. 2002;415:670–672. - PubMed
-
- Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1-2 suppl):97–106. - PubMed
-
- Edrissian GH. Malaria in Iran: past and present situation. Iranian J Parasitol. 2006;1:1–14.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical